JPM
JPMorgan Chase & Co.
JPM has the edge over OPY overall, supported by stronger valuation and stronger modeled upside.
OPY
Oppenheimer Holdings Inc.
OPY trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
OPY Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
OPY's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like OPY.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over OPY in the historical PE scenario, which offers more potential upside but is not a forecast.
OPY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.1x | $30.75 | -66% |
| Fair | 9x | $66.53 | -26% |
| Current | 12x | $89.68 | — |
| Expensive | 13x | $93.25 | +4% |
Historical ranges are pointers, not guarantees.
OPY's PE is in its expensive range at 12x.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
OPY Forward outlook
There aren't enough analyst estimates for OPY to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM's earnings per share have climbed steadily: $23.85 over the past year, up 18% from the year before, and higher year over year for 15 quarters in a row.
OPY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $7.43 | -0.3% |
| Q2 2026 | $8.86 | +15% |
| Q1 2026 | $8.39 | +25% |
| Q4 2025 | $13.04 | +105% |
| Q3 2025 | $7.45 | +15% |
| Q2 2025 | $7.71 | +40% |
| Q1 2025 | $6.72 | +80% |
| Q4 2024 | $6.37 | +146% |
OPY's earnings per share have fallen from their peak: $7.43 over the past year, against $13.28 in late 2021.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over OPY on profitability, with a higher operating margin.
OPY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $382M | -10% |
| Q2 2026 | $454.9M | +22% |
| Q1 2026 | $445.1M | +21% |
| Q4 2025 | $472.6M | +26% |
| Q3 2025 | $424.4M | +14% |
| Q2 2025 | $373.2M | +13% |
| Q1 2025 | $367.8M | +4.2% |
| Q4 2024 | $375.4M | +22% |
OPY has the edge over JPM on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.3% | -5.2 points |
| Q2 2026 | 8.7% | 0 points |
| Q1 2026 | -6.1% | -17 points |
| Q4 2025 | 22% | +18 points |
| Q3 2025 | 7.5% | -2 points |
| Q2 2025 | 8.6% | +3.8 points |
| Q1 2025 | 11% | +0.6 points |
| Q4 2024 | 4.5% | -1.2 points |
OPY's operating margin was 2.3% last quarter, down 5.2 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
OPY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $128.6M | +107% |
| Q2 2026 | -$57.1M | -247% |
| Q1 2026 | -$190M | -$96.6M |
| Q4 2025 | $175.8M | +146% |
| Q3 2025 | $62.2M | +455% |
| Q2 2025 | $38.9M | +$155.6M |
| Q1 2025 | -$93.4M | -$14.1M |
| Q4 2024 | $71.5M | +17% |
OPY has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over OPY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
OPY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +103K shares |
| 1 year | +1.2% | +136K shares |
| 3 years | +1.3% | +146K shares |
| 5 years | -15% | -2.1M shares |
| Available history | -16% | -2.3M shares |
OPY has 12M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $2.3M |
| Q3 2025 | — |
| Q2 2025 | $581,000 |
| Q1 2025 | $90,000 |
| Q4 2024 | — |
OPY spent $2M buying back its own shares over the past year, about three times what it spent the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
OPY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | 1.5x | Healthy |
| Q3 2023 | 1.2x | Healthy |
| Q2 2023 | 1.6x | Healthy |
| Q1 2023 | 1.4x | Healthy |
| Q4 2022 | 0.0x | Very low |
| Q3 2022 | 0.8x | Very low |
| Q2 2022 | 0.6x | Very low |
| Q1 2022 | 0.4x | Very low |
OPY's net debt is about 1.5 years of its operating earnings (EBITDA), up from less than a year a year ago. Net leverage isn't a meaningful measure for financial services companies like OPY.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
OPY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.7 | Neutral |
| Stochastic | 14.4 | Oversold |
OPY's weekly RSI is 39 (neutral) and its Stochastic is 14 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
OPY PE vs Financial Services Sector
| Metric | OPY | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.3% below |
| PE % | 80 | 63 | 17 pts above |
OPY has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over OPY on trend strength, trading above more of its moving averages.
OPY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.8 | 13% below |
| 20 week MA | $109.8 | 18% below |
| 50 week MA | $97.5 | 8.1% below |
| 100 week MA | $82.0 | 9.4% above |
| 200 week MA | $62.7 | 43% above |
OPY has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 43% above its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
OPY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.8 | $31.7 | +14% |
| 2021 | $31.7 | $44.2 | +39% |
| 2022 | $44.2 | $42.8 | -3.2% |
| 2023 | $42.8 | $41.3 | -3.4% |
| 2024 | $41.3 | $64.5 | +56% |
| 2025 | $64.5 | $74.2 | +15% |
| 2026 YTD | $74.2 | $89.7 | +21% |
OPY has the edge over JPM on returns for 2026, with the stronger performance.